Colossolactone E

A fungal metabolite.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Natural product

1
Supporting references
0
Contradictory references
0
AI-suggested references
0
Clinical trials

General information

Colossolactone E on PubChem

 

Structure image - Colossolactone E

CC1=CC[C@@H](OC1=O)[C@@H](C)[C@H]2C[C@H]([C@@]3([C@@]2(CCC4=C3CC[C@@H]5C(=C4)C=CC(=O)OC5(C)C)C)C)OC(=O)C


Supporting references

Link Tested on Impact factor Notes Publication date
Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach
3CLpro Small molecule In silico
in silico 3.08

Predicted to inhibit the SARS-CoV-2 3C-like protease.

Jan/04/2021